Torrent Pharmaceuticals Ltd Statistics
Want to see IN:TORNTPHARM full AI Analyst Report?
Torrent Pharmaceuticals Ltd (TORNTPHARM) Stock Statistics & Valuation Metrics
Total Valuation
Torrent Pharmaceuticals Ltd has a market cap or net worth of INR 1.82T. The enterprise value is INR 1.94T.
- Market Cap
- INR 1.82T
- Enterprise Value
- INR 1.94T
Share Statistics
Torrent Pharmaceuticals Ltd has 380,354,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 380,354,250
- Owned by Insiders
- ―
- Owned by Institutions
- 6.76%
Financial Efficiency
Torrent Pharmaceuticals Ltd’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 6.58%.
- Return on Equity (ROE)
- 0.26
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.58%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 6.87M
- Profits Per Employee
- 1.06M
- Employee Count
- 20,341
- Asset Turnover
- 0.32
- Inventory Turnover
- 2.28
Valuation Ratios
The current PE Ratio of Torrent Pharmaceuticals Ltd is 78.00. Torrent Pharmaceuticals Ltd’s PEG ratio is -22.52.
- PE Ratio
- 78.00
- PS Ratio
- 10.44
- PB Ratio
- 9.85
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -22.52
Income Statement
In the last 12 months, Torrent Pharmaceuticals Ltd had revenue of 139.80B and earned 21.63B in profits. Earnings per share was 63.92.
- Revenue
- 139.80B
- Gross Profit
- 68.24B
- Operating Income
- 34.62B
- Pretax Income
- 28.72B
- Net Income
- 21.63B
- EBITDA
- 32.57B
- Earnings Per Share (EPS)
- 63.92
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Torrent Pharmaceuticals Ltd pays an annual dividend of INR 9.00, resulting in a dividend yield of 0.31%
- Dividend Per Share
- INR 9.00
- Dividend Yield
- 0.31%
- Payout Ratio
- 57.65%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.17%
Stock Price Statistics
- Beta
- 0.43
- 52-Week Price Change
- 24.50%
- 50-Day Moving Average
- 4769.12
- 200-Day Moving Average
- 4545.87
- Relative Strength Index (RSI)
- 56.21
- Average Volume (3m)
- 23.05K
Important Dates
Torrent Pharmaceuticals Ltd upcoming earnings date is Jan 28, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Jan 28, 2027
- Ex-Dividend Date
- May 29, 2026
Financial Position
Torrent Pharmaceuticals Ltd as a current ratio of 1.13, with Debt / Equity ratio of 179.10%
- Current Ratio
- 1.13
- Quick Ratio
- 0.75
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- 4.27
- Interest Coverage Ratio
- 8.99
Taxes
In the past 12 months, Torrent Pharmaceuticals Ltd has paid 7.34B in taxes.
- Income Tax
- 7.34B
- Effective Tax Rate
- 0.26
Enterprise Valuation
Torrent Pharmaceuticals Ltd EV to EBITDA ratio is 34.39, with an EV/FCF ratio of 0.00.
- EV to Sales
- 11.20
- EV to EBITDA
- 34.39
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Torrent Pharmaceuticals Ltd has INR 29.86B in cash and marketable securities with INR 141.07B in debt, giving a net cash position of -INR 111.21B billion.
- Cash & Marketable Securities
- INR 29.86B
- Total Debt
- INR 141.07B
- Net Cash
- -INR 111.21B
- Net Cash Per Share
- -INR 292.39
- Tangible Book Value Per Share
- -INR 241.24
Margins
Gross margin is 51.08%, with operating margin of 22.13%, and net profit margin of 12.24%.
- Gross Margin
- 51.08%
- Operating Margin
- 22.13%
- Pretax Margin
- 16.22%
- Net Profit Margin
- 12.24%
- EBITDA Margin
- 32.56%
- EBIT Margin
- 21.52%
Analyst Forecast
The average price target for Torrent Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 42.06%
- EPS Growth Forecast
- -3.48%
Scores
- Smart Score
- ―
- AI Score
- 67
